Clinical trial
Acetylcysteine in the Prevention of Renal Failure After Bypass Surgery
NCT00211653 · Minneapolis Veterans Affairs Medical Center, U.S. Fed · Completed
Key facts
| NCT number | NCT00211653 |
|---|---|
| Title | Acetylcysteine in the Prevention of Renal Failure After Bypass Surgery |
| Official title | Single Center Randomized Clinical Trial of the Effects of Acetylcysteine in the Prevention of Postoperative Renal Failure |
| Lead sponsor | Minneapolis Veterans Affairs Medical Center, U.S. Fed |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Kidney Failure |
| Intervention type | Drug |
| Interventions | N-Acetylcysteine |
| Enrollment | 102 |
| Start date | Apr 1, 2003 |
| Completion | Nov 1, 2006 |
| First posted | Sep 21, 2005 |
| Last update posted | Sep 19, 2007 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: